The DOI matches its Crossref record.
Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee
Open accessAbstract
Objective: This study aims at evaluating the clinical effects of Platelet Rich Plasma (PRP) and Hyaluronic Acid (HA) as individual treatments for mild to moderate Osteoarthritis (OA) and it also examines the potential synergistic effects of PRP in combination with HA.Research continues to emerge examining the potential therapeutic efficacy of HA and PRP as autologous injectable treatments for joint arthritis.However, there is a paucity of research investigating the effects of combining HA and PRP on pain and functional status in patients with OA.Design: In this multi-center, randomized, controlled, double blind, prospective trial, 105 patients with mild to moderate knee osteoarthritis, who met the study criteria, were randomly allocated to one of three interventions: HA (n=36), PRP (n=36), or HA+PRP (n=33).Each patient received 3 intra-articular knee injections of their assigned substance, with 2 week intervals between each injection.Clinical outcomes were evaluated using the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and Visual Analogue Scale (VAS) questionnaire at baseline and after 1,3,6 and 12 months.Results: The study showed that the PRP group have significant reduction in VAS scores at 1 (p= 0.003), 3 (p= 0.0001), 6 (p= 0.0001) and 12 (p= 0.000) months when compared to HA.In addition, the PRP group illustrated greater improvement in WOMAC physical activity scale at 12 months (p= 0.008) when compared to the HA group.Combining HA and PRP resulted in a significant decreases in pain (p=0.0001) and functional limitation (p=0.0001) when compared to HA alone at 1 year post treatment; and significantly increased physical function at 1 (p=0.0004)and 3 (p=.011)months when compared to PRP alone. Conclusion:The findings of the study support the use of autologous PRP as an effective treatment of mild to moderate knee osteoarthritis.It also shows that the combination of HA and PRP resulted to better outcomes than HA alone up to 1 year and PRP alone up to 3 months.Furthermore, the results suggest that combination of PRP and HA could potentially provide better functional outcomes in the first 30 days after treatment with both PRP and HA alone.the extracellular matrix [4] , providing increased joint lubrication.Studies have demonstrated that HA has positive therapeutic efficacy for knee osteoarthritis with initial efficacy at 4 weeks, and peak effectiveness at 8 weeks which lasts for up to 6 months [5] .When compared to continuous oral NSAIDS or other anti-inflammatory medications, HA has illustrated comparable, if not greater, therapeutic effects on knee OA with a better safety profile [5,6] .Autologous platelet rich plasma (PRP) has also emerged as an alternative in the context of injectable treatment for OA.PRP is comprised of a potent cellular milieu containing platelet concentrations above baseline, as well as an undifferentiated mixture of anti-inflammatory, pro-inflammatory, anabolic and catabolic mediators in an attempt to stimulate a supra-physiologic response and elicit the body's natural healing potential.Currently, most studies on PRP are anecdotal or case reports with small sample sizes.However, larger randomized controlled trials have demonstrated superior efficacy in areas such as tendinopathies [7] and knee osteoarthritis [8] .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021) · The American Journal of Sports Medicine · doi:10.1177/0363546520909397 · Cited by 432
Current Clinical Recommendations for Use of Platelet-Rich Plasma
Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2018) · Current Reviews in Musculoskeletal Medicine · doi:10.1007/s12178-018-9527-7 · Cited by 383
Filardo, G., Previtali, D., Napoli, F., Candrian, C., Zaffagnini, S., & Grassi, A. (2021) · CARTILAGE · doi:10.1177/1947603520931170 · Cited by 294
Di Martino, A., Di Matteo, B., Papio, T., Tentoni, F., Selleri, F., Cenacchi, A., Kon, E., & Filardo, G. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546518814532 · Cited by 272
Mallia, I., Fioravanti, A., & Guiducci, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110408 · Cited by 14
Metadata
- Venue
- Journal of Stem Cells and Regenerative Medicine
- Publisher
- G N Corporation Co Ltd
- Published
- 2016-11-29
- Volume
- 12
- Issue
- 2
- Pages
- 69-78
- ISSN
- 0973-7154 (ISSN-L)
- OpenAlex
- W2582002924
- Cited by
- 217
- References
- 0
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. https://app.cochat.ai/papers/10.46582/jsrm.1202011
- The paper
- Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee. (2016). Journal of Stem Cells and Regenerative Medicine. https://doi.org/10.46582/jsrm.1202011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.